The “Drug Delivery Partnering Terms and Agreements” report a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.